BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23337197)

  • 1. A review of the use of biological agents for chronic inflammatory demyelinating polyradiculoneuropathy.
    Stübgen JP
    J Neurol Sci; 2013 Mar; 326(1-2):1-9. PubMed ID: 23337197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
    Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
    Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
    Haq RU; Pendlebury WW; Fries TJ; Tandan R
    Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of intravenous immunoglobulin in CIDP.
    Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
    Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Nobile-Orazio E; Gallia F
    Curr Opin Neurol; 2015 Oct; 28(5):480-5. PubMed ID: 26203970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
    Hughes RA
    Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential biomarkers for monitoring therapeutic response in patients with CIDP.
    Dalakas MC
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():63-7. PubMed ID: 21696503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammatory demyelinating polyneuropathy: a treatment protocol proposal.
    Odaka M
    Expert Rev Neurother; 2006 Mar; 6(3):365-79. PubMed ID: 16533141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Lehmann HC; Hughes RA; Hartung HP
    Handb Clin Neurol; 2013; 115():415-27. PubMed ID: 23931793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Allen D; Makowska A; Gregson NA
    J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
    Uzenot D; Azulay JP; Pouget J
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2012 Apr; 70(4):715-21. PubMed ID: 22568158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment.
    Eftimov F; Vermeulen M; van Doorn PA; Brusse E; van Schaik IN;
    Neurology; 2012 Apr; 78(14):1079-84. PubMed ID: 22442436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inflammatory demyelinating polyneuropathy.
    Mathey EK; Pollard JD
    J Neurol Sci; 2013 Oct; 333(1-2):37-42. PubMed ID: 23146613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.